189 related articles for article (PubMed ID: 27349480)
1. Pars cohort study of non-communicable diseases in Iran: protocol and preliminary results.
Gandomkar A; Poustchi H; Moini M; Moghadami M; Imanieh H; Fattahi MR; Ayatollahi SM; Sagheb MM; Anushiravani A; Mortazavi R; Sepanlou SG; Malekzadeh R
Int J Public Health; 2017 Apr; 62(3):397-406. PubMed ID: 27349480
[TBL] [Abstract][Full Text] [Related]
2. Tabari Cohort Profile and Preliminary Results in Urban Areas and Mountainous Regions of Mazandaran, Iran.
Kheradmand M; Moosazadeh M; Saeedi M; Poustchi H; Eghtesad S; Esmaeili R; Alizadeh-Navaei R; Hedayatizadeh-Omran A; Nikaeein R; Rafiei A; Janbabaee G; Kashi Z; Sohrab M; Shirzad AhooDashti M; Afshari M; Golpour B; Aarabi M; Maleki I; Tirgar Fakheri H; Ghaemian A; Zarghami M; Ghaemi A
Arch Iran Med; 2019 Jun; 22(6):279-285. PubMed ID: 31356093
[TBL] [Abstract][Full Text] [Related]
3. The PERSIAN Guilan Cohort Study (PGCS).
Mansour-Ghanaei F; Joukar F; Naghipour MR; Sepanlou SG; Poustchi H; Mojtahedi K; Balou HA; Heidarzadeh A; Malekzadeh R
Arch Iran Med; 2019 Jan; 22(1):39-45. PubMed ID: 30821159
[TBL] [Abstract][Full Text] [Related]
4. Non-communicable diseases in the southwest of Iran: profile and baseline data from the Shahrekord PERSIAN Cohort Study.
Ahmadi A; Shirani M; Khaledifar A; Hashemzadeh M; Solati K; Kheiri S; Sadeghi M; Mohammadian-Hafshejani A; Shahraki HR; Asgharzadeh A; Salehifard AZ; Mousavi M; Zarean E; Goujani R; Nazari SSH; Poustchi H; Dugué PA
BMC Public Health; 2021 Dec; 21(1):2275. PubMed ID: 34903205
[TBL] [Abstract][Full Text] [Related]
5. The protocol of a population-based prospective cohort study in southwest of Iran to analyze common non-communicable diseases: Shahrekord cohort study.
Khaledifar A; Hashemzadeh M; Solati K; Poustchi H; Bollati V; Ahmadi A; Kheiri S; Samani KG; Banitalebi M; Sedehi M; Malekzadeh R
BMC Public Health; 2018 May; 18(1):660. PubMed ID: 29801446
[TBL] [Abstract][Full Text] [Related]
6. The PERSIAN Cohort: Providing the Evidence Needed for Healthcare Reform.
Eghtesad S; Mohammadi Z; Shayanrad A; Faramarzi E; Joukar F; Hamzeh B; Farjam M; Zare Sakhvidi MJ; Miri-Monjar M; Moosazadeh M; Hakimi H; Rahimi Kazerooni S; Cheraghian B; Ahmadi A; Nejatizadeh A; Mohebbi I; Pourfarzi F; Roozafzai F; Motamed-Gorji N; Montazeri SA; Masoudi S; Amin-Esmaeili M; Danaie N; Mirhafez SR; Hashemi H; Poustchi H; Malekzadeh R
Arch Iran Med; 2017 Nov; 20(11):691-695. PubMed ID: 29480734
[TBL] [Abstract][Full Text] [Related]
7. Epidemiologic Study of Opium Use in Pars Cohort Study: A Study of 9000 Adults in a Rural Southern Area of Iran.
Fallahzadeh MA; Salehi A; Naghshvarian M; Fallahzadeh MH; Poustchi H; Sepanlou SG; Gandomkar A; Malekzadeh R
Arch Iran Med; 2017 Apr; 20(4):205-210. PubMed ID: 28412823
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of HIV and non-communicable disease (NCD) risk factors in rural KwaZulu-Natal, South Africa.
van Heerden A; Barnabas RV; Norris SA; Micklesfield LK; van Rooyen H; Celum C
J Int AIDS Soc; 2017 Oct; 20(2):. PubMed ID: 29064168
[TBL] [Abstract][Full Text] [Related]
9. Prevalence, awareness, treatment, and control of hypertension and their determinants: Results from the first cohort of non-communicable diseases in a Kurdish settlement.
Rajati F; Hamzeh B; Pasdar Y; Safari R; Moradinazar M; Shakiba E; Bazargan-Hejazi S; Karim H; Najafi F
Sci Rep; 2019 Aug; 9(1):12409. PubMed ID: 31455810
[TBL] [Abstract][Full Text] [Related]
10. The burden and predisposing factors of non-communicable diseases in Mashhad University of Medical Sciences personnel: a prospective 15-year organizational cohort study protocol and baseline assessment.
Tohidinezhad F; Khorsand A; Zakavi SR; Rezvani R; Zarei-Ghanavati S; Abrishami M; Moradi A; Tavakoli M; Farrokh D; Rad MP; Abbasi B; Ahadi M; Saleh LA; Tayebi M; Amini M; Poustchi H; Abu-Hanna A; Eslami S
BMC Public Health; 2020 Nov; 20(1):1637. PubMed ID: 33138802
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of Risk Factors of Major Non-Communicable Diseases among Adolescents of Higher Secondary Schools of Kaski District.
Yadav DK; Sharma B; Shrestha N; Karmacharya I; Yadav S
J Nepal Health Res Counc; 2018 Oct; 16(3):307-312. PubMed ID: 30455491
[TBL] [Abstract][Full Text] [Related]
12. Smoking Water-Pipe, Opium Use and Prevalence of Heart Disease: A Cross-sectional Analysis of Baseline Data from the Pars Cohort Study, Southern Iran.
Adib A; Masoompour SM; Molavi Vardanjani H; Gondomkar A; Poustchi H; Salehi A; Islami F; Malekzadeh R
Arch Iran Med; 2020 May; 23(5):289-295. PubMed ID: 32383612
[TBL] [Abstract][Full Text] [Related]
13. Prevalence, Awareness, Treatment, Control, and Correlates of Hypertension in the Pars Cohort Study.
Gandomkar A; Poustchi H; Malekzadeh F; Malekzadeh MM; Moini M; Moghadami M; Imanieh H; Fattahi MR; Sagheb MM; Ayatollahi SMT; Sepanlou SG; Malekzadeh R
Arch Iran Med; 2018 Aug; 21(8):335-343. PubMed ID: 30113854
[TBL] [Abstract][Full Text] [Related]
14. A province-based surveillance system for the risk factors of non-communicable diseases: A prototype for integration of risk factor surveillance into primary healthcare systems of developing countries.
Alikhani S; Delavari A; Alaedini F; Kelishadi R; Rohbani S; Safaei A
Public Health; 2009 May; 123(5):358-64. PubMed ID: 19386334
[TBL] [Abstract][Full Text] [Related]
15. The prevalence of risk factors associated with non-communicable diseases in Afghan refugees in southern Iran: a cross-sectional study.
Taherifard E; Moradian MJ; Taherifard E; Hemmati A; Rastegarfar B; Molavi Vardanjani H
BMC Public Health; 2021 Mar; 21(1):442. PubMed ID: 33663464
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of non-communicable disease risk factors in community-living patients with psychiatric disorders: A study from North India.
Singh SM; Surendran I; Jain S; Sharma A; Dua D; Shouan A; Avasthi A
Asian J Psychiatr; 2019 Mar; 41():23-27. PubMed ID: 30878917
[TBL] [Abstract][Full Text] [Related]
17. Cohort profile: the Lanxi Cohort study on obesity and obesity-related non-communicable diseases in China.
Wei C; Ye S; Ru Y; Gan D; Zheng W; Huang C; Chen L; Gao P; Li J; Yang M; Yang F; Zhao X; Zhu S
BMJ Open; 2019 May; 9(5):e025257. PubMed ID: 31076469
[TBL] [Abstract][Full Text] [Related]
18. Kharameh cohort study (KHCS) on non-communicable diseases and preliminary findings of 3-year follow-up.
Rezaianzadeh A; Niazkar HR; Rezaeianzadeh R; Jafari F; Rahimikazerooni S; Ghoddusi Johari M; Zare M; Hosseini SV
BMJ Open; 2024 Feb; 14(2):e077116. PubMed ID: 38331866
[TBL] [Abstract][Full Text] [Related]
19. The profile of Rafsanjan Cohort Study.
Hakimi H; Ahmadi J; Vakilian A; Jamalizadeh A; Kamyab Z; Mehran M; Malekzadeh R; Poustchi H; Eghtesad S; Sardari F; Soleimani M; Khademalhosseini M; Abolghasemi M; Mohammadi M; Sadeghi T; Ayoobi F; Abbasi M; Mohamadi M; Jalali Z; Shamsizadeh A; Esmaeili-Nadimi A
Eur J Epidemiol; 2021 Feb; 36(2):243-252. PubMed ID: 32725579
[TBL] [Abstract][Full Text] [Related]
20. The prevalence and predictors of cardiovascular diseases in Kherameh cohort study: a population-based study on 10,663 people in southern Iran.
Baeradeh N; Ghoddusi Johari M; Moftakhar L; Rezaeianzadeh R; Hosseini SV; Rezaianzadeh A
BMC Cardiovasc Disord; 2022 May; 22(1):244. PubMed ID: 35643460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
